Breast cancer

EQS-News: BriaCell’s Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients

Retrieved on: 
Friday, December 2, 2022

BriaCells lead candidate Bria-IMT is marketed as an off-the-shelf personalized cellular approach to immunotherapy for the treatment of advanced solid tumors.

Key Points: 
  • BriaCells lead candidate Bria-IMT is marketed as an off-the-shelf personalized cellular approach to immunotherapy for the treatment of advanced solid tumors.
  • The targeted patients are advanced breast cancer patients or terminal breast cancer patients.
  • BriaCell also reports it is currently developing next-generation off-the-shelf personalized immunotherapies targeting patients with advanced breast cancer and advanced prostate cancer.
  • Bria-OTS+, for advanced breast cancer, and Bria-PROS, for advanced prostate cancer, are designed to activate nave T cells and produce a strong immune response in patients.

Global Cancer/Tumor Profiling Market Report 2022: Technological Advancements in Cancer Profiling Techniques Boosting Sector

Retrieved on: 
Friday, December 2, 2022

The global cancer/tumor profiling market is projected to reach USD 16.0 Billion by 2027 from USD 9.7 Billion in 2022, at a CAGR of 10.6% during the forecast period.

Key Points: 
  • The global cancer/tumor profiling market is projected to reach USD 16.0 Billion by 2027 from USD 9.7 Billion in 2022, at a CAGR of 10.6% during the forecast period.
  • Growth in this market is majorly driven by rising funding investments in cancer research and technological advancements in profiling technologies.
  • Based on cancer type, the cancer/tumor profiling market has been segmented into breast cancer, lung cancer, colorectal cancer, prostate cancer, melanoma, and other cancers.
  • Based on biomarker type, the global cancer/tumor profiling market is segmented into genomic and protein biomarkers.

Bio-Thera Solutions Announces BAT8006 (Folate-Receptor-α-ADC) and BAT8008 (Trop2-ADC) Poster Presentations at the 2022 San Antonio Breast Cancer Symposium

Retrieved on: 
Friday, December 2, 2022

Bio-Thera Solutions, a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and a pipeline of biosimilars, today announced the company will present two posters at the 2022 San Antonio Breast Cancer Symposium (SABCS) taking place December 6 - 10, 2022 in San Antonio, Texas.

Key Points: 
  • Bio-Thera Solutions, a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and a pipeline of biosimilars, today announced the company will present two posters at the 2022 San Antonio Breast Cancer Symposium (SABCS) taking place December 6 - 10, 2022 in San Antonio, Texas.
  • Folate Receptor is a naturally occurring receptor that is overexpressed in many types of cancer, including breast cancer and ovarian cancer.
  • Trop-2 is a naturally occurring receptor that is overexpressed in many types of cancer, including triple negative breast cancer and gastric cancer.
  • This news release contains certain forward-looking statements relating to BAT8006, BAT8008 or the product pipelines in general of Bio-Thera Solutions.

Susan G. Komen 2022 3-Day Event Series Wraps Up Raising $14M

Retrieved on: 
Thursday, December 1, 2022

DALLAS, Dec. 1, 2022 /PRNewswire/ -- More than 5,000 participants took part in the 2022 Susan G. Komen 3-Day event series raising $14 million during the events held in Boston, Chicago, Dallas-Ft. Worth, and San Diego. The Susan G. Komen 3-Day is the longest distance one can go in the fight against breast cancer. Participants each raise a minimum of $2,300 and walk 20 miles a day for three consecutive days, all while educating tens of thousands of people about breast health.

Key Points: 
  • Event series expands for 2023, registration now open
    DALLAS, Dec. 1, 2022 /PRNewswire/ -- More than 5,000 participants took part in the 2022 Susan G. Komen 3-Day event series raising $14 million during the events held in Boston, Chicago, Dallas-Ft. Worth, and San Diego.
  • The Susan G. Komen 3-Day is the longest distance one can go in the fight against breast cancer.
  • Susan G. Komen raised $14 million during the 2022 3-Day event series and announced a new location for 2023.
  • For 2023, the Susan G. Komen 3-Day is expanding the 3-Day event series, adding Denver, Colorado to the event roster.

Breast Cancer Canada announces $500K in new grant funding

Retrieved on: 
Thursday, December 1, 2022

SARNIA, Ontario, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Breast Cancer Canada today announced a call for proposals for their 2023 Precision Oncology Research Grants which will award $500,000 in new funding for breast cancer research projects.

Key Points: 
  • SARNIA, Ontario, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Breast Cancer Canada today announced a call for proposals for their 2023 Precision Oncology Research Grants which will award $500,000 in new funding for breast cancer research projects.
  • "With several Canadian organizations having to reduce funding for breast cancer research, we are proud to continue elevating precision oncology research projects that will have direct impact on patients," said Shaniah Leduc, Chair of Breast Cancer Canada.
  • Together, we are saving lives through breast cancer research" said Kimberly Carson, CEO, Breast Cancer Canada.
  • Breast Cancer Canada (BCC) is a national, registered charity dedicated to saving lives through breast cancer research.

JOIN VICTIMS & ADVOCATES FOR JUSTICE IN DEADLY CAMP LEJEUNE WATER CONTAMINATION

Retrieved on: 
Thursday, December 1, 2022

This year, the government finally acknowledged the harm caused decades ago by the pollution at Camp Lejeune.

Key Points: 
  • This year, the government finally acknowledged the harm caused decades ago by the pollution at Camp Lejeune.
  • Erin Brockovich has joined Ensminger and Partain in seeking justice for Camp Lejeune victims.
  • Together, they pushed for the successful passage of a bill in 2012 to provide healthcare for Camp Lejeune victims.
  • Partain and Ensminger were both featured in an award-winning documentary about the Camp Lejeune contamination, Semper Fi: Always Faithful.

PGT Innovations shows support for four breast cancer non-profits with donation totaling over $9,000

Retrieved on: 
Thursday, December 1, 2022

PGT Innovations (NYSE: PGTI), a leading manufacturer of premium windows, doors, and garage doors, recently donated over $9,000 across four breast cancer non-profits.

Key Points: 
  • PGT Innovations (NYSE: PGTI), a leading manufacturer of premium windows, doors, and garage doors, recently donated over $9,000 across four breast cancer non-profits.
  • PGT Innovations team members across the companys multiple manufacturing plant and office locations purchased over 1,100 t-shirts, raising a total of $8,155.50, which was then donated between the Breast Cancer Research Foundation , the Breast Cancer Alliance , and the Larry Fitzgerald Foundation .
  • Our organization was founded on three core values: serving, leading, and thriving, said Jeff Jackson, PGT Innovations President and CEO.
  • PGT Innovations also donated $1,500 to the American Cancer Society in support of the Making Strides Against Breast Cancer walk event held in Sarasota, FL in mid-October, and several PGTI team members showed their support by participating in the walk.

Renowned Breast Surgical Oncologist Joins NYU Langone Health As Director of Women's Health for Suffolk County

Retrieved on: 
Thursday, December 1, 2022

NEW YORK, Dec. 1, 2022 /PRNewswire/ -- Melissa D. Fana, MD , a leading breast surgical oncologist, has joined NYU Langone Health as director of women's health for Suffolk County and chief of service for breast surgery at Long Island Community Hospital , effective December 1.

Key Points: 
  • NEW YORK, Dec. 1, 2022 /PRNewswire/ -- Melissa D. Fana, MD , a leading breast surgical oncologist, has joined NYU Langone Health as director of women's health for Suffolk County and chief of service for breast surgery at Long Island Community Hospital , effective December 1.
  • She sees patients at Perlmutter Cancer Center at NYU Langone Long Island Breast Surgery AssociatesPatchogue, 100 Hospital Road , suite 106.
  • "These attributes will be a tremendous asset as she develops a comprehensive women's health program in Suffolk County over the next several years."
  • She also previously worked at Plainview Hospital, enhancing their breast surgical program, Brookhaven Hospital Memorial Medical Center, and Brookhaven Breast Health Services.

Insights on the Interventional Oncology Global Market to 2028 - More Efficiency and Quick Recovery Offered by Interventional Oncology is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 1, 2022

The Global Interventional Oncology Market size is expected to reach $2.9 billion by 2028, rising at a market growth of 6.2% CAGR during the forecast period.

Key Points: 
  • The Global Interventional Oncology Market size is expected to reach $2.9 billion by 2028, rising at a market growth of 6.2% CAGR during the forecast period.
  • Interventional oncology (IO) is an emerging subspecialty that emphasizes on using image-guided processes (diagnostics/surgeries) to improve cancer therapy.
  • Along with surgery, medication, and radiation, IO is currently the fourth pillar of modern oncology care.
  • Because of the rising number of cancer cases among individuals around the world, the interventional oncology market is expected to rise faster in the coming years.

REP. BURGESS SELECTED AS CONGRESSIONAL BONE HEALTH CHAMPION AWARD WINNER FOR "OUTSTANDING LEADERSHIP, ADVOCACY AND COMMITMENT"

Retrieved on: 
Thursday, December 1, 2022

(R-Texas) has been selected as a 2022 recipient of the Congressional Bone Health Champion award by the Bone Health and Osteoporosis Foundation (BHOF).

Key Points: 
  • (R-Texas) has been selected as a 2022 recipient of the Congressional Bone Health Champion award by the Bone Health and Osteoporosis Foundation (BHOF).
  • The award annually recognizes Members of Congress who have demonstrated outstanding leadership, advocacy, and commitment to protect and improve the bone health of all Americans.
  • Congress needs to prioritize bone health on our nation's healthcare agenda, and pass legislation to improve bone health screening.
  • Established in 1984, BHOF is the nation'slargest health organization dedicated to osteoporosis and bone health.